ArticleMicrobial genomics2020
Comparative genomics of global
Article in Microbial genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 59 citations in OpenAlex.
- Clonal dissemination of linezolid-resistantInfection prevention in practice · 2026Article
- Prevalence of ARGs in poultry-associatediScience · 2026Article
- Global dissemination of optrA-mediated linezolid resistance in enterococci.The Journal of antimicrobial chemotherapy · 2026Article
- Environmental occurrence of optrA-mediated linezolid resistance in Enterococcus isolates and genomic insights into Enterococcus faecium ST54 co-harboring optrA, poxtA, and cfr(D) genes.World journal of microbiology & biotechnology · 2026Article
- Spread of oxazolidinone-resistant enterococci in an Italian pig slaughterhouse.Frontiers in microbiology · 2026Article
- Identification of the Phenicol Efflux GeneInternational journal of microbiology · 2026Article
- Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum.Antimicrobial agents and chemotherapy · 2025Article
- Linezolid in the Focus of Antimicrobial Resistance ofInternational journal of molecular sciences · 2025Review
- Molecular Epidemiology and Genetic Context ofAntibiotics (Basel, Switzerland) · 2025Article
- Genomics to understand the global landscape of linezolid resistance inMicrobial genomics · 2025Article
- Insights into ecology, pathogenesis, and biofilm formation ofMicrobiology and molecular biology reviews : MMBR · 2025Review
- First Detection and Genomic Characterization of Linezolid-ResistantMicroorganisms · 2025Article
- Genomic Characterization and Phylogenetic Analysis of Linezolid-Resistant Enterococcus from the Nostrils of Healthy Hosts Identifies Zoonotic Transmission.Current microbiology · 2024Article
- Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China.Annals of clinical microbiology and antimicrobials · 2024Article
- High prevalence and plasmidome diversity ofFrontiers in microbiology · 2024Article
- phytools 2.0: an updated R ecosystem for phylogenetic comparative methods (and other things).PeerJ · 2024Article
- Prevalence and genetic diversity ofFrontiers in microbiology · 2024Article
- Prevalence and Associated Factors ofAntibiotics (Basel, Switzerland) · 2023Article
- Co-Existence of Oxazolidinone Resistance GenesAntibiotics (Basel, Switzerland) · 2023Article
- Antibiotic Resistance among Gastrointestinal Bacteria in Broilers: A Review Focused onAnimals : an open access journal from MDPI · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Linezolid-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.